UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1987-1992

2008

Volltextzugriff (PDF)

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Cancer, 2001-11, Vol.92 (9), p.2247-2258

2001

Volltextzugriff (PDF)

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1980-1986

2008

Volltextzugriff (PDF)

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Journal of clinical oncology, 2003-03, Vol.21 (6), p.968-975

2003

Volltextzugriff (PDF)

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Cancer, 2002-11, Vol.95 (9), p.2006-2016

2002

Volltextzugriff (PDF)

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3893-3901

2004

Volltextzugriff (PDF)

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

JCO global oncology, 2021-12, Vol.7 (7), p.811-819

2021

Volltextzugriff (PDF)

Predictive and prognostic significance of CD8 + tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy

Oncology letters, 2017-07, Vol.14 (1), p.337-344

2017

Volltextzugriff (PDF)

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

Cancer, 2006-08, Vol.107 (3), p.472-480

2006

Volltextzugriff (PDF)

Docetaxel-anthracycline combinations in metastatic breast cancer

Breast cancer research and treatment, 2003-01, Vol.79 (S1), p.S3-S9

NABHOLTZ, Jean-Marc A

2003

Volltextzugriff (PDF)

Ocular toxicity and cancer chemotherapy: A review

Cancer, 1996-10, Vol.78 (7), p.1359-1373

1996

Volltextzugriff (PDF)

Responsiveness of the EuroQol in Breast Cancer Patients Undergoing High Dose Chemotherapy

Quality of life research, 2001-01, Vol.10 (6), p.479-486

2001

Volltextzugriff (PDF)

Cardiovascular safety profiles of aromatase inhibitors : A comparative review

Drug safety, 2006-01, Vol.29 (9), p.785-801

2006

Volltextzugriff (PDF)

Liarozole fumarate (R85246) : a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer

Breast cancer research and treatment, 2000, Vol.59 (1), p.55-68

2000

Volltextzugriff (PDF)

Docetaxel in the treatment of breast cancer: current experience and future prospects

Expert review of anticancer therapy, 2005-08, Vol.5 (4), p.613-633

2005

Volltextzugriff (PDF)

Taxane therapy for early stage breast cancer

Women's Health, 2006-01, Vol.2 (1), p.99-114

2006

Volltextzugriff (PDF)

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues

Journal of clinical oncology, 2002-09, Vol.20 (17), p.3748-3750

2002

Volltextzugriff (PDF)

Steroidal side effects of exemestane

Journal of clinical oncology, 2001-04, Vol.19 (7), p.2107-2108

Nabholtz, J M

2001

Volltextzugriff (PDF)

Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor–positive advanced breast carcinoma

Cancer, 2002-12, Vol.95 (11), p.2442-2443

Gluck, Stefan

2002

Volltextzugriff (PDF)

Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer

Breast cancer research and treatment, 2000-11, Vol.64 (2), p.177-188

2000

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

KollektionLWW Total

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Oncology
(18)
Humans
(16)
Breast Neoplasms - Drug Therapy
(14)
Female
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Chemotherapy
(12)
Breast Neoplasms - Pathology
(9)
Pharmacology. Drug Treatments
(9)
Antineoplastic Agents
(7)
Breast Cancer
(7)
Neoplasm Metastasis
(6)
Tumors
(6)
Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Cancer Therapies
(5)
Gynecology. Andrology. Obstetrics
(5)
Mammary Gland Diseases
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(6)
Cancer
(5)
Breast Cancer Research And Treatment
(4)
Drug Safety
(1)
Expert Review Of Anticancer Therapy
(1)
Jco Global Oncology
(1)
Oncology Letters
(1)
Quality Of Life Research
(1)
Women's Health
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial

Predictive and prognostic significance of CD8 + tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

Docetaxel-anthracycline combinations in metastatic breast cancer

Ocular toxicity and cancer chemotherapy: A review

Responsiveness of the EuroQol in Breast Cancer Patients Undergoing High Dose Chemotherapy

Cardiovascular safety profiles of aromatase inhibitors : A comparative review

Liarozole fumarate (R85246) : a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer

Docetaxel in the treatment of breast cancer: current experience and future prospects

Taxane therapy for early stage breast cancer

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues

Steroidal side effects of exemestane

Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor–positive advanced breast carcinoma

Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer

Aktive Filter

Suchergebnisse filtern